Vori Health operates a nationwide physician-led musculoskeletal care platform that integrates board-certified physicians, physical therapists, registered dietitians, and health coaches to deliver coordinated virtual and in-person care. The company’s core product is a value-based care model designed to reduce unnecessary procedures and improve clinical outcomes through cohesive care teams and technology. Reported operating metrics include an 800% revenue increase, 91.6% of patients reporting clinically significant pain improvement, a 78–90% reduction in elective orthopedic surgeries, a 42% decrease in opioid utilization, up to a 68% reduction in depression and anxiety, and a verified 4:1 claims-based ROI. Vori says its platform has been adopted by Fortune 200 companies and national health plans, driving payer and employer demand. Future plans include deepening value-based care initiatives (including evolution toward two-sided population health risk), investing in advanced data analytics to better target high-risk members, and enhancing its AI-powered technology platform and clinical programs. The new funding is intended to scale the physician-led care model nationwide and expand its economic models and analytics capabilities. Vori Health offers a virtual-first musculoskeletal care platform that combines technology, premium content, community features, and multidisciplinary care teams to treat a range of conditions. The company provides an integrated care team, care navigation, group classes, educational content, community forums, blogging, live messaging, and immersive care. Vori positions its product as human-centered and evidence-based to address the fragmented, costly care pathways in musculoskeletal health, a sector the article cites as a $300B market and the top cause of global disability affecting 54% of the U.S. population. The platform is full-stack and customizable to individual patient needs, and Vori reports growing interest from practice groups and expanding partnerships. With the new funding, the company plans to accelerate technology, product, services, and data buildout along with clinical and support-team growth.

Total raised

$98M

Funding rounds

2

Latest round

Series B

Latest activity

Mar 2025